172@29@17@105!~!172@29@0@53!~!|news|business|earnings|ipca-laboratories-q1-pat-seen-up-34-1-yoy-to-rs-87-9-cr-prabhudas-lilladher-4199571.html!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : Jul 12, 2019 05:08 PM IST | Source: Moneycontrol.com

IPCA Laboratories Q1 PAT seen up 34.1% YoY to Rs. 87.9 cr: Prabhudas Lilladher

Net Sales are expected to increase by 14 percent Y-o-Y (up 16.8 percent Q-o-Q) to Rs. 973.5 crore, according to Prabhudas Lilladher.

Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its first quarter (April-June’ 19) earnings estimates for the Pharma sector. The brokerage house expects IPCA Laboratories to report net profit at Rs. 87.9 crore up 34.1% year-on-year (down 19.7% quarter-on-quarter).


Net Sales are expected to increase by 14 percent Y-o-Y (up 16.8 percent Q-o-Q) to Rs. 973.5 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 26.2 percent Y-o-Y (down 17.6 percent Q-o-Q) to Rs. 143.9 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Jul 12, 2019 05:08 pm
Sections